Athena Athena

X

Digital content for Cyxone AB

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Cyxone AB
Sweden Flag
Country
Country
Sweden
Address
Address
Adelgatan 21, 211 22 Malmö
Telephone
Telephone
+46 708 882 172
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.contractpharma.com/contents/view_breaking-news/2023-03-09/cyxone-streamlines-manufacturing-process-for-rabeximod/?widget=listSection

CONTRACT PHARMA
09 Mar 2023

https://ipohub.io/companies/cyxone-ab/news/nomination-committee-appointed-for-cyxone-annual-general-meeting-2023-081120221235

IPOHUB
08 Nov 2022

https://news.cision.com/cyxone/r/cyxone-will-leverage-ind-and-use-fda-pre-review-for-covid-19-phase-2-trial,c3421070

CISION
24 Sep 2021

https://news.cision.com/cyxone/r/cyxone-and-medical-university-of-vienna-announce-collaboration-to-study-broader-t20k-use-in-ms,c3377799

CISION
01 Jul 2021

https://news.cision.com/cyxone/r/cyxone-initiates-feasibility-preclinical-studies-to-optimize-path-forward-for-multiple-sclerosis-dru,c3342352#:~:text=Swedish-,Cyxone%20Initiates%20Feasibility%20Preclinical%20Studies%20to%20Optimize%20Path,Multiple%20Sclerosis%20Drug%20Candidate%20T20K&text=Cyxone%20announced%20today%20the%20initiation,Sclerosis%20drug%20candidate%20T20K%20forward.

CISION
06 May 2021

https://www.prnewswire.com/news-releases/cyxone-reports-first-covid-19-patient-screened-in-phase-2-clinical-trial-of-rabeximod-301209286.html#:~:text=STOCKHOLM%2C%20Jan.%2015%2C%202021,of%20Rabeximod%20in%20Covid%2D19.

PRNEWSWIRE
15 Jan 2021

https://www.prnewswire.com/news-releases/cyxone-has-filed-an-ind-in-the-us-with-rabeximod-following-positive-feed-back-from-pre-ind-meeting-with-the-fda-301192673.html

PRNEWSWIRE
15 Dec 2020

https://www.clinicaltrialsarena.com/news/cyxone-trial-oral-drug/

CLINICALTRIALSARENA
09 Dec 2020

https://www.prnewswire.com/news-releases/cyxone-receives-regulatory-approval-to-initiate-a-clinical-phase-2-study-with-rabeximod-in-covid-19-patients-301188427.html

PRNEWSWIRE
08 Dec 2020

https://www.prnewswire.com/news-releases/cyxone-files-patent-application-to-extend-exclusivity-of-rabeximod-301169999.html#:~:text=Cyxone%20files%20patent%20application%20to%20extend%20exclusivity%20of%20Rabeximod,-News%20provided%20by&text=STOCKHOLM%2C%20Nov.%2010%2C%202020,other%20territories%20in%20due%20course.

PRNEWSWIRE
10 Nov 2020
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY